Improve arm dexterity with robotics
- Trial ID
- NCT06906679
- Official Title
- Effectiveness of a Robotic End-effector Device for Upper Limb Rehabilitation in People With Parkinson's Disease: a Multicenter Randomized Controlled Pilot Study
- Goal
- Improve arm dexterity with robotics
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- IRCCS San Raffaele Roma
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson Disease
- Interventions
- Experimental Group, control group
Plain-Language Summary
The goal is to help people with moderate Parkinson's improve upper limb movement, strength, coordination and everyday arm use. A robotic end-effector device attaches at the hand or wrist and guides repetitive, assisted reaching, grasping and fine-motor exercises, giving consistent movement patterns and sensory feedback to promote motor relearning and reduce stiffness; the multicenter trial randomly compares robot-assisted sessions to standard care. They are enrolling about 40 people aged 30 to 80 with Parkinson's by UK Brain Bank criteria, Hoehn and Yahr stage 2 to 3 while ON, a MoCA score of at least 17.54, stable medications for 4 or more weeks, and the ability to follow and consent to the exercise program.
Locations
- San Raffaele Cassino, Cassino, FR, Italy
- IRCCS San Raffaele Roma, Rome, Lazio, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Experimental Group. The goal is to help people with moderate Parkinson's improve upper limb movement, strength, coordination and everyday arm use. A robotic end-effector device attaches at the hand or wrist and guides repetitive, assisted reaching, grasping and fine-motor exercises, giving consistent movement patterns and sensory feedback to promote motor relearning and reduce stiffness; the multicenter trial randomly compares robot-assisted sessions to standard care. They are enrolling about 40 people aged 30 to 80 with Parkinson's by UK Brain Bank criteria, Hoehn and Yahr stage 2 to 3 while ON, a MoCA score of at least 17.54, stable medications for 4 or more weeks, and the ability to follow and consent to the exercise program.
- Who can participate?
- Participants must be between 30 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.